Mo Heidaran

Dr. Mo Heidaran is currently Chief Scientist at Cellx Inc. and Founder of CHCF a non profit organization with interest in discovery and development of gene based biomarkers for diagnosis of serious brain disorders. He is a recognized expert in the development of cell and gene therapies with more than 9 years of experience at the FDA’s working in both product and compliance offices (CBER/OTP/OCBQ), 3+ years in a large CRO, Parexel as VP of Technical, and 15+ years as Director R&D in biotech industry working in companies like Celgene, BD, and GC Therapeutics. He is currently a member of the International Society of Cell Therapy Legal and Regulatory Affair Committee, and United State Pharmacopeia Bio5 Expert Committee. He is the founder of the new Gordon Research Conference on Synthetic Biology in 2000. He also holds 25 issued patents and 54 pending patents, and his work has appeared in more than 50 peer-reviewed scientific publications.